Day: December 17, 2025

RAS AL KHAIMAH, United Arab Emirates, Dec. 16, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, announced today that it will deliver an FX Super One MPV to Ras Al Khaimah (“RAK”) Innovation City on December 22, marking the Company’s upcoming second FX Super One delivery in the UAE.FF operates a regional production and operations center in Ras Al Khaimah, designed to support production for both FF and FX vehicles. FX has signed a strategic cooperation with RAK Innovation City to accelerate a regional new energy mobility ecosystem and plans to advance phase II expansion of its operations facility in Ras Al Khaimah. This planned delivery follows the Company’s first FX Super One...

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) — ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen”, the “Company”) and MTB Metals Corp. (TSXV: MTB, OTCQB: MBYMF, Frankfurt: M9U) (“MTB”): ExGen and MTB are pleased to announce that at the special meeting of securityholders of MTB held on December 11, 2025 (the “Meeting”), MTB shareholders (“Shareholders”) and optionholders (together with the Shareholders, the “Securityholders”) voted overwhelmingly in favour of the previously announced plan of arrangement (the “Arrangement”) between MTB and ExGen. Additionally, today, MTB received a final order of the Supreme Court of British Columbia approving the Arrangement. Under the Arrangement, ExGen will acquire all of the issued and outstanding securities of MTB. In consideration therefore, each one MTB share will be exchanged...

BRISBANE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced that it has granted inducement to a new non-executive employee under the terms of the 2022 Employment Inducement Award Plan. The equity award was approved on December 10, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4). The new non-executive employee received an option to purchase 19,000 shares of Annexon common stock. The option carries a ten-year term and an exercise price per share equal to $4.91, which was the closing price of Annexon’s common stock on December 15, 2025, the date of grant, and vests over 4 years, with 25% of the shares...

— First-in-human trial of candidate from the next-generation ATTC platform — — Simultaneous China and global clinical development strategy to expedite development process — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces the initiation of its global Phase I clinical development program for HMPL-A251, a first-in-class PI3K/PIKK-HER2 Antibody-Targeted Therapy Conjugate (“ATTC”) comprising a highly selective and potent PI3K/PIKK inhibitor payload conjugated to a humanized anti-HER2 IgG1 antibody via a cleavable linker. Study sites are in the US and China. The first patient received the first dose on December 16, 2025, in China. This first-in-human Phase I/IIa, open-label, multicenter clinical study evaluates HMPL-A251...